Abstract
Glucagon is a 29-amino acid pancreatic hormone which counteracts the blood glucose-lowering action of insulin by stimulating hepatic glycogenolysis and gluconeogenesis1. The structure of the hamster pancreatic glucagon precursor has recently been determined from the sequence of a cloned cDNA2. Hamster preproglucagon is a 180-amino acid protein which contains five functional regions; a signal or pre-peptide, an NH2-terminal peptide (also called glicentin-related pancreatic peptide, GRPP), glucagon, and two carboxy-terminal glucagon-like peptides (GLP-1 and GLP-2). The sequences of two non-allelic anglerfish pancreatic glucagon precursors3–5 have also been determined and their organization is similar but not identical to the hamster protein; they lack the polypeptide segment corresponding to hamster GLP-2. The presence of three regions possessing internal homology, that is, glucagon, GLP-1 and GLP-2, within proglucagon, and the absence of GLP-2 in the anglerfish precursors suggests that the structure of the preproglucagon gene might provide insight into the evolution of this polyprotein. We have isolated and sequenced the human preproglucagon gene and report here that the organization of the human precursor deduced from this sequence is identical to the hamster protein. The gene contains at least three intervening sequences which divide the protein-coding portion of the gene into four regions corresponding to the signal peptide and part of the NH2-terminal peptide, the remainder of the NH2-terminal peptide and glucagon, GLP-1, and GLP-2. The data suggest that triplication and subsequent sequence divergence of an exon encoding glucagon or a glucagon-like peptide produced this polyprotein precursor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Unger, R. H. & Orci, L. New Engl. J. Med. 304, 1518–1524 (1981).
Bell, G. I., Santerre, R. F. & Mullenbach, G. T. Nature 302, 716–718 (1983).
Lund, P. K., Goodman, R. H., Montminy, M. R., Dee, P. C. & Habener, J. F. J. biol. Chem. 258, 3280–3284 (1983).
Lund, P. K., Goodman, R. H. & Habener, J. F. J. biol. Chem. 256, 6515–6518 (1981).
Shields, D., Warren, T. G., Roth, S. E. & Brenner, M. J. Nature 289, 511–514 (1981).
Lawn, R. M., Fritsch, E. F., Parker, R. C., Blake, G. & Maniatis, T. Cell 15, 1157–1174 (1978).
Breathnach, R. & Chambon, P. A. Rev. Biochem. 50, 349–383 (1981).
Manley, J. L., Fire, A., Cano, A., Sharp, P. A. & Gefter, M. L. Proc. natn. Acad. Sci U.S.A. 77, 3855–3859 (1980).
Mount, S. M. Nucleic Acids Res. 10, 459–471 (1982).
Foa, P., Bajaj, J. & Foa, N. (eds) Glucagon: Its Role in Physiology and Clinical Medicine (Springer, Berlin, 1977).
Unger, R. H.& Orci, L. (eds) Glucagon, Physiology, Pathophysiology and Morphology of the Pancreatic A-cell (Elsevier, New York, 1981).
Conlon, J. M. Diabetologia 18, 85–88 (1980).
Tager, H. S. & Markese, J. J. biol. Chem. 254, 2229–2233 (1979).
Thim, L. & Moody, A. J. Regul. Peptides 2, 139–150 (1981).
Bataille, D. et al. FEBS Lett. 146, 79–86 (1982).
Dayhoff, M. O. Atlas of Protein Sequence and Structure Vol. 5, Suppl. 2, 125–126 (National Biomedical Research Foundation, Washington, 1976).
Blanchetot, A., Wilson, V., Wood, D. & Jeffreys, A. J. Nature 301, 732–734 (1983).
Zakut, R. et al. Nature 298, 857–859 (1982).
Chang, A. C. Y., Cochet, M. & Cohen, S. N. Proc. natn. Acad. Sci. U.S.A. 77, 4890–4894 (1980).
Whitfield, P. L., Seeburg, P. H. & Shine, J. DNA 1, 133–143 (1982).
Noda, M. et al. Nature 297, 431–434 (1982).
Efstratiadis, A. et al. Cell 21, 653–668 (1980).
Lauer, J., Shen, C-K. J. & Maniatis, T. Cell 20, 119–130 (1980).
Seeburg, P. H. DNA 1, 239–249 (1982).
Kidd, V. J. & Saunders, G. F. J. biol. Chem. 157, 10673–10680 (1982).
Moore, D. D., Conkling, M. A. & Goodman, H. M. Cell 29, 285–286 (1982).
Lawn, R. M. et al. Science 212, 1159–1162 (1981).
Ullrich, A., Gray, A., Goeddel, D. V. & Dull, T. J. J. molec. Biol. 156, 467–486 (1982).
Gilbert, W. Nature 271, 501 (1978).
Bell, G. I. et al. Nature 282, 525–527 (1979).
Santerre, R. F. et al. Proc. natn. Acad. Sci. U.S.A. 78, 4339–4343 (1981).
Southern, E. M. J. molec. Biol. 98, 503–517 (1975).
O'Farrell, P. Focus 3 (3), 1–3 (1981).
Wahl, G. M., Stern, M. & Stark, G. R. Proc. natn. Acad. Sci. U.S.A. 76, 3683–3687 (1979).
Perler, F. et al. Cell 20, 555–566 (1980).
Maxam, A. M. & Gilbert, W. Meth. Enzym. 65, 499–560 (1980).
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H. & Roe, B. A. J. molec. Biol. 143, 161–178 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bell, G., Sanchez-Pescador, R., Laybourn, P. et al. Exon duplication and divergence in the human preproglucagon gene. Nature 304, 368–371 (1983). https://doi.org/10.1038/304368a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/304368a0
This article is cited by
-
Metabolic Messengers: glucagon
Nature Metabolism (2023)
-
The expanding incretin universe: from basic biology to clinical translation
Diabetologia (2023)
-
The Biological Role of Optimized Recombinant Oral Long-Acting Glucagon Like Peptide-1 and Its Impact on the Expression of Genes Associated with Glucose Metabolism of Diabetes
International Journal of Peptide Research and Therapeutics (2021)
-
First-in-class positron emission tomography tracer for the glucagon receptor
EJNMMI Research (2019)
-
Effects of metformin and Exenatide on insulin resistance and AMPKα-SIRT1 molecular pathway in PCOS rats
Journal of Ovarian Research (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
